[Cardiovascular system research at the Institute of Drug Research].
The most significant achievements in the cardiovascular research areas have been reviewed. Among the beta-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, beta-adrenoceptor blocker).